PRAXIS Resource Repository Search our extensive library of COPD care and readmissions reduction resources, including best practices, research articles, educational materials and toolkits.
Return to all articles Return to previous page Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPD Resource Type: Research Papers 0 Comments | 1 Likes The COPD Biomarkers Qualification Consortium (CBQC) is a partnership between the COPD Foundation, the U.S. Food and Drug Administration (FDA) and the pharmaceutical industry developed in part to demonstrate that individual biomarkers can be used effectively in the drug development process. This paper presents the process and outcomes of a project seeking approval of fibrinogen, a measure of inflammation, as a biomarker for use in clinical COPD trials. View Resource Citation: Mannino DM, Tal-Singer R, Lomas DA, et al. Plasma fibrinogen as a biomarker for mortality and hospitalized exacerbations in people with COPD. J COPD F. 2015; 2(1): 23-34. https://journal.copdfoundation.org/jcopdf/id/1043/Plasma-Fibrinogen-as-a-Biomarker-for-Mortality-and-Hospitalized-Exacerbations-in-People-with-COPD. Accessed March 19, 2020. exacerbations hospitalization No Comments You need to login to comment.
Return to all articles Return to previous page Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPD Resource Type: Research Papers 0 Comments | 1 Likes The COPD Biomarkers Qualification Consortium (CBQC) is a partnership between the COPD Foundation, the U.S. Food and Drug Administration (FDA) and the pharmaceutical industry developed in part to demonstrate that individual biomarkers can be used effectively in the drug development process. This paper presents the process and outcomes of a project seeking approval of fibrinogen, a measure of inflammation, as a biomarker for use in clinical COPD trials. View Resource Citation: Mannino DM, Tal-Singer R, Lomas DA, et al. Plasma fibrinogen as a biomarker for mortality and hospitalized exacerbations in people with COPD. J COPD F. 2015; 2(1): 23-34. https://journal.copdfoundation.org/jcopdf/id/1043/Plasma-Fibrinogen-as-a-Biomarker-for-Mortality-and-Hospitalized-Exacerbations-in-People-with-COPD. Accessed March 19, 2020. exacerbations hospitalization No Comments You need to login to comment.
Join Us on COPD360social Join the Conversation Become a Member > Already a Member? Sign In to Participate >
Type of Resource View All Articles Articles (35) Case Studies (10) Educational Materials (9) Opinion/Editorials (10) Policy Statements (3) Presentations (5) Research Papers (80) Statistics (9) Toolkits (24) Webinars (8) White Papers/Reports (12)
Tags View All Articles 97readmission79hospitalization61treatment55patient education55care coordination54promising practices50evaluation & quality improvement45patient experience43exacerbations42co-morbidities42post-acute care38caregiver & community34telehealth28behavioral health27pulmonary rehabilitation27risk stratification25public policy22ambulatory care21diagnosis18prevention16HRRP13socioeconomic issues13exercise12oxygen12Palliative care5nutrition4hospice4Alpha-13readmissions2quality improvement1caregiver1COPD1care transitions1treatment guidelines1GOLD1improving care1COVID-191research & quality improvement1hospitalizations